LB Pharmaceuticals Commences ~$150M Offering Of Common Shares, Pre-Funded Warrants
LB Pharmaceuticals Inc ("LB Pharmaceuticals" or the "Company") (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple
LB Pharmaceuticals is raising about $150 million by selling new shares to investors, which gives them money to keep developing medicines but dilutes existing shareholders' ownership. When a company does this, watch whether they spend the money wisely on drug research and whether their stock price recovers as progress happens.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.